[ASAP] Modulation of Nanostructure-Based Lipopolysaccharide Active Immunotherapy in Cancer: Size and Composition Determine Short- and Long-Term Tolerability

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.9b00631

Source: Molecular Pharmaceutics - October 1, 2019 Category: Drugs & Pharmacology Authors: Maryam A. Shetab Boushehri †, Tawfek Yazeji†, Valentin Stein‡, and Alf Lamprecht*†§ Source Type: research